Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01A25-year analysis of Armillaria (honey mushroom) poisoning in Wisconsin.The American journal of emergency medicine · 2026-08-01Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”PLOS One · 2026-06-30Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice.Proceedings of the National Academy of Sciences of the United States of America · 2026-06-16Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorderTranslational Psychiatry · 2026-05-26Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Serotonergic Polypharmacology of 2-Halogenated Tryptamines.bioRxiv: the preprint server for biology · 2026-04-21Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFocus · 2026-04-01A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28Compassionate use of psilocybin for treatment-resistant depression in Germany.The lancet. Psychiatry · 2026-02-01A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-01-12Associations of Couples' Psychedelic Use with Shared Reality and Relational Well-Being.Journal of psychoactive drugs · 2026-01-06Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.Journal of psychoactive drugs · 2026-01-01Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.Journal of psychopharmacology (Oxford, England) · 2026-01-01Contextualizing Violence Risk Associated With Hallucinogens.Focus (American Psychiatric Publishing) · 2026-01-01A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.Addiction (Abingdon, England) · 2025-12-22Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.Journal of affective disorders · 2025-11-15Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-04Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.Psychiatry and clinical psychopharmacology · 2025-07-30Psychedelic drugs for the treatment of substance use disorders.Expert review of clinical pharmacology · 2025-07-010391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart StudySLEEP · 2025-04-30Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.Biology direct · 2025-04-10166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-09Is there a place for psychedelics in sports practice?Acta neuropsychiatrica · 2025-03-21Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-19Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study.Journal of psychoactive drugs · 2025-03-05Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.Journal of affective disorders · 2025-01-15Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.Current pain and headache reports · 2025-01-07Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Therapeutic advances in psychopharmacology · 2025-01-01Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders.Journal of clinical psychopharmacology · 2025-01-01Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.Deutsches Arzteblatt international · 2024-12-27Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.Neuroscience and biobehavioral reviews · 2024-12-01Will Psychedelics Propel Your Career? Exploring the Potential Impact of Psychedelics on Work, Productivity and Well-BeingHuman capital leadership. · 2024-11-01Effects of psilocybin on uncertain punishment learning.Neurobiology of learning and memory · 2024-09-01How psilocybin affects the brain.Nature medicine · 2024-07-30Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study.Focus (American Psychiatric Publishing) · 2024-07-01Innovative and Emerging Treatments for Anorexia Nervosa.Focus (American Psychiatric Publishing) · 2024-07-01A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomesJournal of Psychedelic Studies · 2024-04-05Neural effects of psilocybin-treatment in patients with treatment-resistant depressionNeuroscience Applied · 2024-01-01Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military VeteransClinicalTrials.gov · 2023-05-25The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24Psilocybin zeigt Wirkung bei Depression.MMW Fortschritte der Medizin · 2023-04-01Wirkt Psilocybin nachhaltig antidepressiv?InFo Neurologie + Psychiatrie · 2023-02-01Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.Journal of affective disorders · 2023-02-01Efficacy and Safety of Psychedelics in Treating Anxiety Disorders.Ochsner journal · 2023-01-01Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.Neuropsychiatric disease and treatment · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01Psilocybin therapy reduces heavy drinking.Nature medicine · 2022-09-08Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.Irish journal of medical science · 2022-06-01The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.Journal of psychopharmacology (Oxford, England) · 2022-03-01Hallucinogen chemistry guides antidepressant drug discoveryC&EN Global Enterprise · 2022-02-06Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.CNS drugs · 2022-01-01Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience applied · 2022-01-01Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.Frontiers in psychiatry · 2022-01-01P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-12-01Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activityZenodo (CERN European Organization for Nuclear Research) · 2021-11-29A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic HealingJournal of Humanistic Psychology · 2021-09-16Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.Neurobiology of learning and memory · 2021-09-01Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions.Drug testing and analysis · 2021-09-01Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.Pharmacopsychiatry · 2021-07-01Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2021-01-01Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2020-07-01Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.Psychopharmacology · 2020-05-01Tripping on nothing: placebo psychedelics and contextual factors.Psychopharmacology · 2020-05-01Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01Microdosing psychedelics: Motivations, subjective effects and harm reduction.The International journal on drug policy · 2020-01-01Psychedelic Microdosing: A Subreddit Analysis.Journal of psychoactive drugs · 2020-01-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of psychopharmacology (Oxford, England) · 2018-01-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of psychopharmacology (Oxford, England) · 2016-12-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-16The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-16Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybinDrug and Alcohol Dependence · 2014-06-07Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the scientific study of religion · 2012-12-01Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.Journal of psychopharmacology (Oxford, England) · 2011-11-01The occurrence of psilocybin in Gymnopilus species.Lloydia · 1978-01-01A new behavior change program using psilocybin.Psychotherapy · 1965-01-01REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.The Journal of nervous and mental disease · 1963-12-01The Hallucinogenic Mushrooms of Mexico and Psilocybin: a BibliographyBotanical Museum leaflets Harvard University · 1962-09-07